Advances in MUC1 resistance to chemotherapy in pancreatic cancer.
1/5 보강
The incidence of pancreatic cancer (PC), a highly fatal malignancy, is increasing every year.
APA
Yao Y, Fan D (2024). Advances in MUC1 resistance to chemotherapy in pancreatic cancer.. Journal of chemotherapy (Florence, Italy), 36(6), 449-456. https://doi.org/10.1080/1120009X.2023.2282839
MLA
Yao Y, et al.. "Advances in MUC1 resistance to chemotherapy in pancreatic cancer.." Journal of chemotherapy (Florence, Italy), vol. 36, no. 6, 2024, pp. 449-456.
PMID
38006297 ↗
Abstract 한글 요약
The incidence of pancreatic cancer (PC), a highly fatal malignancy, is increasing every year. Chemotherapy is an important treatment for it in addition to surgery, yet most patients become resistant to chemotherapeutic agents within a few weeks of treatment initiation. MUC1 is a highly glycosylated transmembrane protein, and studies have shown that aberrantly glycosylated overexpression of MUC1 is involved in regulating the biology of chemoresistance in cancer cells. This article summarizes the mechanism of MUC1 in PC chemoresistance and reviews MUC1-based targeted therapies.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Ionizable mesoporous silica nanoparticle-mediated siAURKB delivery for colorectal cancer therapy.
- The comparative diagnostic and therapeutic application value of FAPI PET/CT and F-FDG PET/CT in oncology.
- Integrated Single-Cell and Bulk Transcriptome Analysis Reveals the Prognostic Significance and Immune Regulatory Mechanisms of Sialylation in Hepatocellular Carcinoma.
- Microbiota in cancer: current understandings and future perspectives.
- Parthenolide and Its Derivatives in the Treatment of Respiratory Tract Diseases: Therapeutic Effects and Molecular Mechanisms.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.